Veracyte (VCYT)
(Delayed Data from NSDQ)
$20.63 USD
+0.51 (2.53%)
Updated May 9, 2024 04:00 PM ET
After-Market: $20.62 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 37% (92 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.92 | 1.57 | 9.99 |
Current Quarter Estimate | -0.05 | 3.93 | 57.00 |
Year Ago Quarter Estimate | -0.12 | 3.85 | 52.54 |
Next Quarter Estimate | -0.03 | 3.92 | 61.00 |
Next Year Estimate | 0.05 | 19.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 71.57 | 13.50 | 15.67 |
Next Year | 117.24 | 22.20 | 9.31 |
Last 5 Years | NA | 9.90 | 8.10 |
Next 5 Years | NA | 15.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 29.13 |
Price/Book (MRQ) | 1.41 | 2.44 |
Price/Cash Flow (MRFY) | 216.78 | 15.17 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -18.16% | -4.54% |
Return on Equity (TTM) | -1.44% | -1.65% |
Debt to Equity (MRQ) | NA | 27.03 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.